Shell plc Form 6-K Summary: Q2 2025 Outlook Update
Business Context and Reporting Period
This Form 6-K, dated July 7, 2025, provides an updated outlook for Shell plc's second quarter of 2025 (Q2'25). The filing compares Q2'25 expectations against actual Q1'25 results. Final Q2'25 results are scheduled for publication on July 31, 2025. All outlook figures exclude identified items unless otherwise noted.
Key Financial Metrics and Segment Outlook
The filing details segment-specific expectations for production, margins, and earnings. Key metrics include:
- Integrated Gas: Production expected at 900–940 kboe/d (vs. 927 kboe/d in Q1). LNG liquefaction volumes at 6.4–6.8 MT. Adjusted EBITDA and earnings are projected with lower trading and optimization contributions than Q1.
- Upstream: Production expected at 1,660–1,760 kboe/d (vs. 1,855 kboe/d in Q1), reflecting scheduled maintenance and the completed sale of SPDC in Nigeria. Exploration well write-offs are expected to be ~$0.2 billion.
- Marketing: Sales volumes expected at 2,600–3,000 kb/d. Adjusted earnings are projected to be higher than Q1'25.
- Chemicals and Products: Indicative refining margin expected at $8.9/bbl (up from $6.2/bbl in Q1). Indicative chemicals margin at $166/tonne (up from $126/tonne). However, the segment is expected to report adjusted earnings below break-even due to a loss in the Chemicals sub-segment and lower trading/optimization. Refinery utilization is expected to rise to 92–96%, while Chemicals utilization drops to 68–72% due to unplanned maintenance at Monaca.
- Renewables and Energy Solutions: Adjusted earnings expected between $(0.4) and $0.2 billion, with trading and optimization lower than Q1.
- Corporate: Adjusted earnings expected between $(0.6) and $(0.4) billion.
- Cash Flow (Shell Group): Tax paid expected at $2.8–3.6 billion. Working capital movements expected to range from $(1) to $4 billion. Derivative movements expected between $(1) and $3 billion.
Material Changes Versus Prior Period
Significant operational and financial shifts are anticipated compared to Q1'25:
- Production Declines: Upstream production is expected to decrease due to maintenance and the SPDC divestment. Integrated Gas production is expected to remain relatively stable but slightly lower.
- Margin Improvements: Both indicative refining and chemicals margins are projected to increase significantly compared to Q1.
- Utilization Variance: While refinery utilization is expected to improve, chemicals utilization will decline due to unplanned maintenance.
- Trading Impact: Trading and optimization results are expected to be significantly lower across Integrated Gas, Chemicals & Products, and Renewables segments compared to Q1.
- Formula Updates: The formulas for Indicative Refining Margin (IRM) and Indicative Chemicals Margin (ICM) were updated following the Singapore divestment. Applying the old formula would have yielded lower margins ($7.5/bbl and $143/tonne respectively).
Guidance, Risks, and Unusual Items
Guidance and Outlook: The company refers to the "Quarterly Databook" for full-year price and margin sensitivities. Consensus estimates managed by Vara Research are expected on July 23, 2025.
Unusual Items and Contingencies:
- Unplanned Maintenance: Impacted Chemicals utilization at the Monaca facility.
- Divestments: Completed sale of SPDC in Nigeria and Singapore divestment affecting margin calculations.
- Exploration Write-offs: Expected ~$0.2 billion in Q2'25.
Risks: The filing includes standard forward-looking statement disclaimers citing risks such as crude oil and natural gas price fluctuations, demand changes, currency fluctuations, geopolitical conflicts (Russia-Ukraine, Middle East), regulatory developments regarding climate change, and cyber security incidents.
Investor Verification Checklist
- Verify the impact of the SPDC Nigeria sale on Q2'25 Upstream production volumes and earnings.
- Confirm the extent of the "significantly lower" trading and optimization results across multiple segments compared to Q1.
- Monitor the resolution of unplanned maintenance at the Monaca chemicals facility and its effect on utilization rates.
- Review the updated formulas for IRM and ICM to ensure accurate margin comparisons against historical data.
- Assess the final Q2'25 results (due July 31, 2025) against the provided outlook ranges, particularly for Chemicals & Products earnings which are expected to be below break-even.